MRI Detection of Lymph Node Metastasis through Molecular Targeting of C-C Chemokine Receptor Type 2 and Monocyte Hitchhiking ACS Nano. 2024 Jan 23; 18(3):2091-2104. . View in PubMed

Cell State and Cell Type: Deconvoluting Circulating Tumor Cell Populations in Liquid Biopsies by Multi-Omics Cancers (Basel). 2023 Aug 03; 15(15). . View in PubMed

Immune biomarkers associated with COVID-19 disease severity in an urban, hospitalized population Pract Lab Med. 2023 Aug; 36:e00323. . View in PubMed

Synthesis and anti-cancer potential of potent peripheral MAOA inhibitors designed to limit blood:brain penetration Bioorg Med Chem. 2023 09 07; 92:117425. . View in PubMed

Phase 2 trial of monoamine oxidase inhibitor phenelzine in biochemical recurrent prostate cancer Prostate Cancer Prostatic Dis. 2021 03; 24(1):61-68. . View in PubMed

In Vivo Non-Thermal, Selective Cancer Treatment With High-Frequency Medium-Intensity Focused Ultrasound IEEE Access. 2021; 9:122051-122066. . View in PubMed

Effect of Periodized Resistance Training on Skeletal Muscle During Androgen Deprivation Therapy for Prostate Cancer: A Pilot Randomized Trial Integr Cancer Ther. 2021 Jan-Dec; 20:15347354211035442. . View in PubMed

CCR2-targeted micelles for anti-cancer peptide delivery and immune stimulation J Control Release. 2021 01 10; 329:614-623. . View in PubMed

Monitoring dynamic cytotoxic chemotherapy response in castration-resistant prostate cancer using plasma cell-free DNA (cfDNA) BMC Res Notes. 2019 May 15; 12(1):275. . View in PubMed

Randomized Phase II Trial of Abiraterone Alone or With Dasatinib in Men With Metastatic Castration-resistant Prostate Cancer (mCRPC)Clin Genitourin Cancer. 2019 08; 17(4):241-247. e1. . View in PubMed

Effect of Monoamine oxidase A (MAOA) inhibitors on androgen-sensitive and castration-resistant prostate cancer cells Prostate. 2019 05; 79(6):667-677. . View in PubMed

Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis Oncogene. 2019 04; 38(16):3003-3018. . View in PubMed

Identification, characterization and application of a new peptide against anterior gradient homolog 2 (AGR2) Oncotarget. 2018 Jun 08; 9(44):27363-27379. . View in PubMed

Loss of MAOA in epithelia inhibits adenocarcinoma development, cell proliferation and cancer stem cells in prostate Oncogene. 2018 09; 37(38):5175-5190. . View in PubMed

Impact of resistance training on body composition and metabolic syndrome variables during androgen deprivation therapy for prostate cancer: a pilot randomized controlled trial BMC Cancer. 2018 04 03; 18(1):368. . View in PubMed

Protein Mimetic and Anticancer Properties of Monocyte-Targeting Peptide Amphiphile Micelles ACS Biomater Sci Eng. 2017 Dec 11; 3(12):3273-3282. . View in PubMed

Safety and Efficacy of Docetaxel, Bevacizumab, and Everolimus for Castration-resistant Prostate Cancer (CRPC) Clin Genitourin Cancer. 2017 Jul 14. . View in PubMed

A pilot randomised controlled trial of a periodised resistance training and protein supplementation intervention in prostate cancer survivors on androgen deprivation therapy BMJ Open. 2017 Jul 10; 7(7):e016910. . View in PubMed

Androgen receptor in cancer-associated fibroblasts influences stemness in cancer cells Endocr Relat Cancer. 2017 04; 24(4):157-170. . View in PubMed

Automated analysis of co-localized protein expression in histologic sections of prostate cancer PLoS One. 2017; 12(5):e0178362. . View in PubMed

A review of clinical effects associated with metabolic syndrome and exercise in prostate cancer patients Prostate Cancer Prostatic Dis. 2016 12; 19(4):323-332. . View in PubMed

Salvage ablative therapy in prostate cancer: international multidisciplinary consensus on trial designUrol Oncol. 2015 Nov; 33(11):495. e1-7. . View in PubMed

Trans-rectal ultrasound visibility of prostate lesions identified by magnetic resonance imaging increases accuracy of image-fusion targeted biopsies World J Urol. 2015 Nov; 33(11):1669-76. . View in PubMed

Blood-based gene expression profiling in castrate-resistant prostate cancer BMC Med. 2015 Sep 14; 13:219. . View in PubMed

A novel technique using three-dimensionally documented biopsy mapping allows precise re-visiting of prostate cancer foci with serial surveillance of cell cycle progression gene panel Prostate. 2015 Jun; 75(8):863-71. . View in PubMed

Intolerance of uncertainty, cognitive complaints, and cancer-related distress in prostate cancer survivors Psychooncology. 2015 Feb; 24(2):228-35. . View in PubMed

Radium 223: how can we optimize this new tool for metastatic castration-resistant prostate cancer? Am Soc Clin Oncol Educ Book. 2015; e270-3.. View in PubMed

Expression and functional role of orphan receptor GPR158 in prostate cancer growth and progression PLoS One. 2015; 10(2):e0117758. . View in PubMed

A Phase II trial of a combination herbal supplement for men with biochemically recurrent prostate cancer Prostate Cancer Prostatic Dis. 2014 Dec; 17(4):359-65. . View in PubMed

Phase I/II trial of orteronel (TAK-700)--an investigational 17,20-lyase inhibitor--in patients with metastatic castration-resistant prostate cancer Clin Cancer Res. 2014 Mar 01; 20(5):1335-44. . View in PubMed

Rapid phenotypic and genomic change in response to therapeutic pressure in prostate cancer inferred by high content analysis of single circulating tumor cells PLoS One. 2014; 9(8):e101777. . View in PubMed

Body image predicts quality of life in men with prostate cancer Psychooncology. 2013 Apr; 22(4):756-61. . View in PubMed

Anterior gradient 2 (AGR2): blood-based biomarker elevated in metastatic prostate cancer associated with the neuroendocrine phenotype Prostate. 2013 Feb 15; 73(3):306-15. . View in PubMed

Prostate cancer: Age is nothing but a number Nat Rev Urol. 2013 12; 10(12):683-4. . View in PubMed

Safety and preliminary efficacy analysis of the mTOR inhibitor ridaforolimus in patients with taxane-treated, castration-resistant prostate cancer Clin Genitourin Cancer. 2012 Dec; 10(4):232-8. . View in PubMed

Prospective evaluation of 18F-NaF and 18F-FDG PET/CT in detection of occult metastatic disease in biochemical recurrence of prostate cancer Clin Nucl Med. 2012 Jul; 37(7):637-43. . View in PubMed

Focal cryotherapy for clinically unilateral, low-intermediate risk prostate cancer in 73 men with a median follow-up of 37 years. Eur Urol. 2012 Jul; 62(1):55-63. . View in PubMed

Multimodality imaging in biochemical recurrence of prostate cancer: utility of (18)F-NaF PET/CT in early detection of metastasis Rev Esp Med Nucl Imagen Mol. 2012 Jul-Aug; 31(4):231-2. . View in PubMed

Quantitative proteomic profiling identifies protein correlates to EGFR kinase inhibition Mol Cancer Ther. 2012 May; 11(5):1071-81. . View in PubMed

3-Dimensional elastic registration system of prostate biopsy location by real-time 3-dimensional transrectal ultrasound guidance with magnetic resonance/transrectal ultrasound image fusion J Urol. 2012 Mar; 187(3):1080-6. . View in PubMed

Cytometric comparisons between circulating tumor cells from prostate cancer patients and the prostate-tumor-derived LNCaP cell line Phys Biol. 2012 Feb; 9(1):016002. . View in PubMed

Safety and pharmacokinetics of high-dose gefitinib in patients with solid tumors: results of a phase I study Cancer Chemother Pharmacol. 2012 Jan; 69(1):273-80. . View in PubMed

Cilengitide (EMD 121974, NSC 707544) in asymptomatic metastatic castration resistant prostate cancer patients: a randomized phase II trial by the prostate cancer clinical trials consortium Invest New Drugs. 2011 Dec; 29(6):1432-40. . View in PubMed

Once-daily dasatinib: expansion of phase II study evaluating safety and efficacy of dasatinib in patients with metastatic castration-resistant prostate cancer Urology. 2011 May; 77(5):1166-71. . View in PubMed

Show us a sign: the search for "game changing" prostate cancer biomarkers Lancet Oncol. 2011 Mar; 12(3):204-6. . View in PubMed

The epothilones: new therapeutic agents for castration-resistant prostate cancer Oncologist. 2011; 16(10):1349-58. . View in PubMed

Detection of androgen receptor mutations in circulating tumor cells in castration-resistant prostate cancer Clin Chem. 2010 Sep; 56(9):1492-5. . View in PubMed

Beta-2-microglobulin expression correlates with high-grade prostate cancer and specific defects in androgen signaling Prostate. 2010 Aug; 70(11):1201-10. . View in PubMed

Predictors of affect following treatment decision-making for prostate cancer: conversations, cognitive processing, and coping Psychooncology. 2009 May; 18(5):508-14. . View in PubMed

Rare mutations of the PIK3CA gene in malignancies of the hematopoietic system as well as endometrium, ovary, prostate and osteosarcomas, and discovery of a PIK3CA pseudogene Leuk Res. 2007 Jan; 31(1):27-32. . View in PubMed

Ductal adenocarcinoma of the prostate Clin Adv Hematol Oncol. 2004 Jun; 2(6):393-5; discussion 396. . View in PubMed

Targeting the HER-kinase axis in cancer Semin Oncol. 2004 Feb; 31(1 Suppl 3):9-20. . View in PubMed

Update on HER-kinase-directed therapy in prostate cancer Clin Adv Hematol Oncol. 2004 Jan; 2(1):53-664. . View in PubMed